Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
JPMORGAN CHASE & CO
> ADAP
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Adaptimmune Therapeutics PLC | ADAP | 1,304,914 | 1,071 | 1,207,045,000 | -213,955,000 | $925.00 |
| 03/31/2023 | Adaptimmune Therapeutics PLC | ADAP | 1,303,843 | 297,011 | 1,421,000,000 | 1,419,917,000 | $1,089.86 |
| 09/30/2022 | Adaptimmune Therapeutics PLC | ADAP | 1,006,832 | -467,331 | 1,083,000 | -1,423,000 | $1.08 |
| 06/30/2022 | Adaptimmune Therapeutics PLC | ADAP | 1,474,163 | 74,398 | 2,506,000 | -378,000 | $1.70 |
| 03/31/2022 | Adaptimmune Therapeutics PLC | ADAP | 1,399,765 | -78,273 | 2,884,000 | -2,658,000 | $2.06 |
| 12/31/2021 | Adaptimmune Therapeutics PLC | ADAP | 1,478,038 | -118,223 | 5,542,000 | -2,711,000 | $3.75 |
| 09/30/2021 | Adaptimmune Therapeutics PLC | ADAP | 1,596,261 | -260,062 | 8,253,000 | 345,000 | $5.17 |
| 06/30/2021 | Adaptimmune Therapeutics PLC | ADAP | 1,856,323 | 170,603 | 7,908,000 | -1,043,000 | $4.26 |
| 03/31/2021 | Adaptimmune Therapeutics PLC | ADAP | 1,685,720 | 656,917 | 8,951,000 | 3,406,000 | $5.31 |
| 12/31/2020 | Adaptimmune Therapeutics PLC | ADAP | 1,028,803 | 560,490 | 5,545,000 | 1,958,000 | $5.39 |
| 09/30/2020 | Adaptimmune Therapeutics PLC | ADAP | 468,313 | -31,918 | 3,587,000 | -1,420,000 | $7.66 |
| 06/30/2020 | Adaptimmune Therapeutics PLC | ADAP | 500,231 | 403,494 | 5,007,000 | 4,743,000 | $10.01 |
| 03/31/2020 | Adaptimmune Therapeutics PLC | ADAP | 96,737 | 20,531 | 264,000 | 173,000 | $2.73 |
| 12/31/2019 | Adaptimmune Therapeutics PLC | ADAP | 76,206 | -240,623 | 91,000 | -387,000 | $1.19 |
| 09/30/2019 | Adaptimmune Therapeutics PLC | ADAP | 316,829 | 38,709 | 478,000 | -632,000 | $1.51 |
| 06/30/2019 | Adaptimmune Therapeutics PLC | ADAP | 278,120 | -124,234 | 1,110,000 | -620,000 | $3.99 |
| 03/31/2019 | Adaptimmune Therapeutics PLC | ADAP | 402,354 | -33,924 | 1,730,000 | -779,000 | $4.30 |
| 12/31/2018 | Adaptimmune Therapeutics PLC | ADAP | 436,278 | 287,753 | 2,509,000 | 495,000 | $5.75 |
| 09/30/2018 | Adaptimmune Therapeutics PLC | ADAP | 148,525 | -63,465 | 2,014,000 | -502,000 | $13.56 |
| 06/30/2018 | Adaptimmune Therapeutics PLC | ADAP | 211,990 | 26,330 | 2,516,000 | 431,000 | $11.87 |
| 03/31/2018 | Adaptimmune Therapeutics PLC | ADAP | 185,660 | 164,704 | 2,085,000 | 1,945,000 | $11.23 |
| 12/31/2017 | Adaptimmune Therapeutics PLC | ADAP | 20,956 | 11,352 | 140,000 | 62,000 | $6.68 |
| 09/30/2017 | Adaptimmune Therapeutics PLC | ADAP | 9,604 | 3,514 | 78,000 | 51,000 | $8.12 |
| 06/30/2017 | Adaptimmune Therapeutics PLC | ADAP | 6,090 | -14,500 | 27,000 | -86,000 | $4.43 |
| 03/31/2017 | Adaptimmune Therapeutics PLC | ADAP | 20,590 | -13,253 | 113,000 | -24,000 | $5.49 |
| 12/31/2016 | Adaptimmune Therapeutics PLC | ADAP | 33,843 | 12,756 | 137,000 | -12,000 | $4.05 |
| 09/30/2016 | Adaptimmune Therapeutics PLC | ADAP | 21,087 | 21,087 | 149,000 | 149,000 | $7.07 |
| << Prev Next >> |
|